Record mula sa primary source
Decision-gradePag-apruba ng FDA
Rocket Pharmaceuticals, Inc. · Pinahintulutan ng FDA ang kresladi (marnetegragene autotemcel)
FDA's Purple Book lists BLA 125806 (kresladi, marnetegragene autotemcel; Rocket Pharmaceuticals Inc, CBER) as licensed on 2026-03-26.
Mahahalagang fact
- Na-file
- Mar 26, 2026, 12:00 AM
- Kaganapan
- Pag-apruba ng FDA
- Direksyon
- Positibo
- Kumpanya
RCKTRocket Pharmaceuticals- Pinagmulan
- Pinagmulan
- Kumpiyansa
- May source
- Kalendaryo
- Desisyon ng FDA (PDUFA) · Mar 28, 2026 · Inaprubahan
Higit pa tungkol sa asset na ito
Abr 28, 2026
11:34 AM
RCKTRocket PharmaceuticalsRocket Pharmaceuticals ibinenta ang KRESLADI PRV sa halagang $180 milyon
Peb 26, 2026
09:21 PM
RCKTRocket PharmaceuticalsNob 6, 2025
09:04 PM
RCKTRocket Pharmaceuticals